Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Genprex Inc (GNPX)

Genprex Inc (GNPX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Genprex Inc 1601 Trinity Street Suite 3.322 AUSTIN TX 78712 USA

P: 512-537-7997

Description:

Genprex Inc. operates as a biotechnology company. It discovers and develops immunogene therapies for cancer treatment as well as clinical research, gene therapies, consulting and other related medical services. The company's initial product candidate is Oncoprex(TM) immunogene therapy which treats non-small cell lung cancer. Genprex Inc. is based in United States.

Key Statistics

Overview:

Market Capitalization, $K 223,309
Shares Outstanding, K 43,277
Annual Sales, $ 0 K
Annual Net Income, $ -10,650 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,775 K
60-Month Beta -0.56
% of Insider Shareholders 13.05%
% of Institutional Shareholders 16.20%
Float, K 37,629
% Float 86.95%

Growth:

1-Year Return 31.06%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 03/29/21
Earnings Per Share ttm -0.32
EPS Growth vs. Prev Qtr 40.00%
EPS Growth vs. Prev Year 50.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

GNPX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -3.84
Price/Earnings to Growth N/A
Return-on-Equity % -81.49%
Return-on-Assets % -79.54%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 8.98
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar